Signature Resources Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.5K Buy
87
+1
+1% +$342 0.01% 198
2026
Q1
$30.3K Sell
86
-3
-3% -$1.07K 0.01% 178
2025
Q4
$29.1K Buy
89
+7
+9% +$2.22K 0.01% 173
2025
Q3
$23.1K Hold
82
0.01% 194
2025
Q2
$22.9K Buy
82
+11
+15% +$3.12K 0.01% 194
2025
Q1
$22.1K Hold
71
0.02% 149
2024
Q4
$18.5K Hold
71
0.02% 155
2024
Q3
$22.9K Hold
71
0.02% 142
2024
Q2
$22.2K Hold
71
0.02% 148
2024
Q1
$20.4K Hold
71
0.02% 144
2023
Q4
$20.4K Buy
+71
New +$19.3K 0.02% 146

Other funds holding AMGN

Signature Resources Capital Management's AMGN Position: Q2 2026 in Review

Signature Resources Capital Management increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $342 and bringing the position to 87 shares worth $31.5K. The position accounts for 0.01% of the portfolio, ranked #198.

Signature Resources Capital Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Signature Resources Capital Management held 87 shares of Amgen worth $31.5K as of Q2 2026.
  • Signature Resources Capital Management bought 1 Amgen share in Q2 2026, an estimated $342.
  • Amgen made up 0.01% of Signature Resources Capital Management's portfolio in Q2 2026, its #198 holding.
  • Signature Resources Capital Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Signature Resources Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.